logo

For the Inventor, By the Inventor

Kurashiki, Japan

Yoshiji Fujita

This inventor holds 37 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Terpene Chemistry. Top assignees: Kuraray Co., Ltd., Taisho Pharmaceutical Co., Ltd., Cytopathfinder, Inc.. Active years: 1976-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiji Fujita. Retrieved from https://idiyas.com/inventor/yoshiji-fujita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 37 

% Patents Active = 97.3


Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 228(Granted Patents)


Location History:

  • Kurashiki, JA (1976 - 1977)
  • Yokohama, JP (1989)
  • Kurashiki, JP (1978 - 1995)
  • Tsukuba, JP (2010)

Company Filing History:

goldMedal36 out of 1,872 
 
Kuraray Co., Ltd.
 patents
silverMedal2 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
bronzeMedal1 out of 2 
 
Cytopathfinder, Inc.
 patents
4. 1 out of 1,766 
 
National Institute of Advanced Industrial Science and Technology
 patents
where one patent can have more than one assignee

Years Active: 1976-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclic Terpenoids
Terpene Amino Alcohols
Chroman Compounds
Dihydrobenzopyran Derivatives
Pesticidal Compositions
Farnesylacetic Acid
Propargyl Alcohols
Ionones
Unsaturated Aldehydes
Stereospecific Esters
Hydroquinone Derivatives
Diacetylene Diol
37 patents (USPTO):Explore Patents
1. 7846903 - Type II cubic liquid crystal composition (2010-12-07),
2. 5428056 - Terpene amino alcohols and medicinal uses thereof (1995-06-27),
3. 5284850 - Terpene amino alcohols and medicinal uses thereof (1994-02-08),
4. 5143921 - Terpene amino alcohols and medicinal uses thereof (1992-09-01),
5. 4946857 - Terpene amino alcohols and medicinal uses thereof (1990-08-07),
6. 4924030 - Process for preparing cyclic terpenoids (1990-05-08),
7. 4886916 - Process for preparing sulfone compounds (1989-12-12),
8. 4827056 - Process for preparing chlorinated olefins (1989-05-02),
9. 4745229 - Process for preparing .alpha., .beta.-unsaturated aldehydes (1988-05-17),
10. 4728650 - 3,4-dihydrobenzopyran derivatives and medicinal uses thereof (1988-03-01),
11. 4694090 - Chroman compounds useful as analgerics and antioxidants (1987-09-15),
12. 4681890 - 3,4-dihydrobenzopyran compounds and pharmaceutical composition (1987-07-21),
13. 4659510 - Trimethylcyclohexenyl compounds and aroma compositions containing the (1987-04-21),
14. 4603208 - Certain polyprenyl intermediates (1986-07-29),
15. 4532258 - Certain cyclopropane carboxylic acid esters and their pesticidal use (1985-07-30),

Title: Yoshiji Fujita: Pioneering Inventor from Kurashiki

Introduction: Yoshiji Fujita is a renowned inventor hailing from Kurashiki, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yoshiji Fujita's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge medical devices for minimally invasive surgeries.

Career Highlights: With over two decades of experience in research and development, Fujita has led numerous projects that have resulted in patented inventions that have revolutionized various industries.

Collaborations: Throughout his career, Yoshiji Fujita has collaborated with leading universities, research institutions, and tech companies to bring his innovative ideas to life and create tangible solutions for complex challenges.

Conclusion: Yoshiji Fujita's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the world of inventions, with a lasting impact on the future of science and engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…